Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein level

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-0895|31|6|562-571

ISSN： 1520-7552

Source： DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol.31, Iss.6, 2015-09, pp. : 562-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Serum ALT Levels during Pegylated Interferon Monotherapy May Be Caused by Hepatic Iron Overload

By  

Intervirology, Vol. 51, Iss. 1, 2008-06 ,pp. : 76-85

Karger

Access to resources Recommend Favorite

SERUM LACTIC DEHYDROGENASE ISOENZYMES IN DIABETES AND CHLORPROPAMIDE THERAPY

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 19, Iss. 12, 1971-12 ,pp. : 983-988

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 2, 2018-02 ,pp. : 342-349

John Wiley & Sons Inc

Access to resources Recommend Favorite

INSULIN AND GLUCAGON SECRETION IN HEPATIC GLYCOGENOSES

By  

ACTA PAEDIATRICA, Vol. 68, Iss. 5, 1979-09 ,pp. : 735-738

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12‐month trial including 6‐month extension

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 12, 2015-12 ,pp. : 1142-1149

John Wiley & Sons Inc

Access to resources Recommend Favorite